Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
96.41 CHF | +1.01% |
|
-39.82% | -47.70% |
15/07 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
12/07 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
Performance
1 day | +1.01% | ||
Current month | -47.70% | ||
Current year | -47.70% |
Volumes
marketsBasic data
Highs and lows
![Extreme 96.40800000](/images/extremecours_fleche.png)
![Extreme 96.40800000](/images/extremecours_fleche.png)
![Extreme 96.40800000](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+1.01% | -39.82% | -47.70% | - | 46.56B | ||
-0.39% | +1.90% | +45.38% | -5.55% | 41.67B | ||
+3.13% | +9.35% | +0.69% | +5.37% | 41.16B | ||
-2.48% | -1.93% | +30.52% | +26.75% | 32.4B | ||
+1.57% | +6.85% | +22.30% | +40.59% | 28.18B | ||
0.00% | +0.80% | -6.35% | +19.28% | 28.1B | ||
+0.28% | +1.72% | +49.25% | +41.46% | 14.52B | ||
+2.88% | +11.28% | +49.18% | +88.02% | 13.74B | ||
+3.38% | +11.97% | +3.45% | -5.22% | 12.17B | ||
+5.11% | +12.61% | -3.85% | +9.52% | 11.14B | ||
+1.84% | +6.27% | -4.92% | -10.27% | 9.27B | ||
+1.67% | +6.49% | +63.08% | +75.43% | 7.59B | ||
+0.81% | +4.56% | +30.64% | +109.17% | 7.48B | ||
+1.67% | +0.06% | +31.23% | +12.09% | 7.03B | ||
+4.77% | +5.95% | -1.48% | +17.33% | 6.94B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | +1.58% | +5.02% | +17.43% | +30.28% | ||
Weighted average by Cap. | +1.10% | +4.88% | +11.04% | +22.56% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
- Stock Market
- Equities
- MRNA Stock
- 0QF Stock
- Quotes Moderna, Inc.